Objective-Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an adult-onset neurovascular disorder caused by stereotyped mutations in the NOTCH3 receptor. Elucidation of its pathobiology is still incomplete and remains a challenge, in part because the available preclinical mouse models to date do not reproduce the full spectrum of CADASIL pathology and clinical disease. Methods and Results-Here, we report a novel knock-in mouse with Arg170Cys substitution in murine Notch3, corresponding to the prevalent Arg169Cys substitution in CADASIL. The Notch3 Arg170Cys mice displayed late-onset, dominant CADASIL arteriopathy with typical granular osmiophilic material deposition and developed brain histopathology including thrombosis, microbleeds, gliosis, and microinfarction. Furthermore, Notch3
C erebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL) is an adult-onset autosomal dominant neurovascular disorder. [1] [2] [3] The main symptoms are migraine with aura, psychiatric disturbances, and recurrent subcortical ischemic strokes causing motor disabilities, cognitive decline, dementia, and premature death. 2, 3 The accompanying arteriopathy is characterized by the progressive degeneration of arterial smooth muscle cells (SMCs), deposition of electron-dense granular osmiophilic material (GOM) within the basal lamina of the SMCs and pericytes, and accumulation of the Notch3 extracellular cleavage product at the SMC membrane. [2] [3] [4] [5] [6] [7] Although the arteriopathy is systemic, 8 the symptoms are mostly neurological. Brain pathology involves microbleeds, loss of myelin or axons, fibrillar gliosis, and lacunar infarcts in the white and deep gray matter. 2, 3, 9 CADASIL is caused by mutations in the transmembrane receptor Notch3, which is predominantly expressed in adult arterial SMCs. 10 -13 Pathogenic mutations stereotypically affect the number of cysteine residues in the epidermal growth factor-like repeats of the extracellular domain (ECD). [13] [14] [15] Thus far, more than 180 mutations are known, nearly 60% of which cluster in exon 4. 3, [13] [14] [15] [16] In vitro and in vivo studies have highlighted a role of Notch3 in artery maturation, responses to vascular injury or ischemia, and regulation of SMC proliferation and apoptosis. [17] [18] [19] [20] [21] [22] [23] [24] [25] How the various Notch3 mutations effectuate arteriopathy and CADASIL disease development remains enigmatic.
Previous approaches to generating a model of CADASIL include knock-in mice carrying the counterpart Arg141Cys CADASIL mutation (Arg142Cys in mouse) in the endogenous Notch3 gene, which failed, however, to develop any phenotype at all. 26 On the other hand, transgenic overexpression in mice of human or rat Notch3 carrying archetypal Notch3 mutations (Arg90Cys human Notch3, [27] [28] [29] [30] Cys428Ser human Notch3, 31 Arg169Cys rat Notch3, 32 Cys455Arg and Arg1031Cys human Notch3 33 ) met with more success, with all models displaying the CADASIL arteriopathy. However, only 1 of them (Arg169Cys rat Notch3) developed brain histopathology, albeit limited to leukoaraiosis and astrogliosis, 32 and none of the models developed neurological symptoms. 7, 33, 34 Here, we report a novel mutant mouse carrying an Arg170Cys knock-in mutation in the endogenous murine Notch3 that, to the best of our knowledge, constitutes the first model comprising both CADASIL histopathology and clinical disease.
Methods

Generation of the Mice
For details on the generation, genotyping, and expression analysis of the Arg170Cys knock-in mice, see the supplemental material, available online at http://atvb.ahajournals.org. Experimental mice were littermates from heterozygous breeding (genetic background overall 50% 129EvSv:50% Swiss). Given the dominant phenotype (see below), experiments were done with heterozygous or homozygous mice, except for expression analyses, which were consistently performed with material from homozygous mutant mice. This study was approved by the ethical committee for animal experimentation of the University of Leuven, Belgium.
Phenotypic Analysis
Expression analysis by quantitative reverse transcription-polymerase chain reaction and by Western blotting was as described in the supplemental material. Notch3 signaling functionality was evaluated by target expression analysis in brain tissue and in vitro in an activation assay using cocultures of embryonic fibroblasts derived from wild-type and mutant embryos, with human umbilical vein endothelial cells (see supplemental material). Tissue preparation and (immuno)histochemical analysis, vascular morphometric analysis, and ultrastructural analysis of brain and peripheral tissues are detailed in the supplemental material.
Mice were monitored during aging for spontaneous motor abnormalities (reduced spontaneous mobility, tremor, ataxia as observed by staggering gait, and limb paresis as observed by dragging of a limb when stimulated to walk on a tabletop).
Arterial remodeling or regrowth was assessed in the lung during pulmonary hypertension 35 and in the skin during healing of a full-thickness skin wound, 36 as detailed in the supplemental material.
Behavioral testing was performed using cognitive and anxiety/ exploratory tests (elevated plus maze, open field exploration, social exploration, passive avoidance test, contextual fear conditioning, radial maze test) as described. 37, 38 Introduction of an Arg170Cys substitution in murine Notch3, corresponding to the prevalent CADASIL Arg169Cys substitution, 14 was achieved by knock-in of the corresponding CGT-to-TGT mutation in exon 4 of the murine gene (Supplemental Figure IA and IB). The resulting mutant mice had normal expression levels of the mutant Notch3 and did not compensatorily upregulate other Notch receptors (Supplemental Note I and Supplemental Table I ). The mutant mice displayed normal growth, viability, and fertility (data not shown). Given the dominant effect of the mutation in our model (see below and Supplemental Note II), heterozygous and homozygous mice are collectively named Notch3
Arg170Cys mice.
Arg170Cys Knock-In Mice Develop Cerebral and Systemic CADASIL Arteriopathy With GOM Deposition
To verify whether the Notch3 Arg170Cys mice developed the typical ultrastructural abnormalities of CADASIL arteriopathy, brains of aged mice were analyzed by electron microscopy. Mice Ϸ20 months old (9 Notch3 Arg170Cys mice and 5 wild-type littermate controls) were analyzed to maximize the likelihood of disease development. Typical abnormalities were observed in Notch3
Arg170Cys mice but not wild-type littermates (Figure 1 ). GOM deposits in the basal lamina of the SMCs and surrounding matrix, a hallmark of CADASIL, were found ( Figure 1A and 1C-1E) . GOM was frequently located in indentations of the SMC membrane ( Figure 1D and 1E), which was often associated with abundance of caveolae and endosomal vesicles ( Figure 1E ), as reported in CADASIL patients. 27, 39 We occasionally also observed GOM-like material inside caveolae ( Figure 1F ). Enlargement of the subendothelial space ( Figure 1G ), enlargement of the SMC intercellular space, and the presence of a multilayered endothelial basement membrane ( Figure 1G and 1H) was seen, as also reported in CADASIL. 4, 40 SMC and endothelial cell vacuolization, indicating cellular degeneration, and occasional SMC necrosis were also observed ( Figure 1D and data not shown). These CADASIL-like ultrastructural abnormalities 2, 4, 7, 34, 40 were found in 67% (6 of 9) of the mutant mice analyzed at this age but never in wild-type littermates (nϭ5) ( Figure 1B ). They were most easily detected in the brain slices corresponding to Ϸ2 mm on either side of bregma. No abnormalities were seen in Notch3
Arg170Cys mice analyzed at the age of 4 to 5 months (nϭ4; data not shown).
Unlike the case in CADASIL patients and most of the other mouse models, 3, 5, 27, 31, 32 we did not obtain evidence for accumulation of the Notch3 ectodomain (by Western blotting for Notch3 ECD and Notch3 intracellular domain; Supplemental Figure IC) .
Arteriopathy in CADASIL patients is systemic, allowing diagnosis by skin biopsy analysis. 4 In accordance with this, we also observed ultrastructural abnormalities in tail arteries in Notch3
Arg170Cys mice (Supplemental Figure II) . This peripheral arteriopathy was observed from 8 to 9 months onward in 67% (4 of 6) of the mutants, equaling the incidence of arteriopathy observed in the brain.
Thus, Notch3 Arg170Cys mice displayed typical CADASIL ultrastructural abnormalities in cerebral and peripheral vessels. The arteriopathy was detected in both females and males and regardless of homo-or heterozygosity (see Supplemental Note II), indicating a dominant effect of the mutation, as in CADASIL. 2, 3, 41 
Arg170Cys Knock-In Mice Display CADASIL-Like Brain Histopathology
To define whether the mutant mice developed the cerebral histopathology observed in CADASIL, histopathologic analysis was carried out on a large group of mice (nϭ73), again at more advanced age (20 -22 months) to maximize detection of cerebral events. Abnormalities were detected in 23% (17) of the Notch3
Arg170Cys mice but not in wild-type brains (nϭ19) (for overview of incidence and features, see Supplemental Table II ). Brain abnormalities included perivascular microbleeds (12%) ( Figure 2A and 2B); hemosiderin deposits or hemosiderin-containing macrophages (visible by Perl's iron staining), indicating previous microbleeds 42 (5.5%) (Figure 2C) ; perivascular inflammatory infiltrates (CD45 ϩ ; data not shown) (8%) ( Figure 2D and 2E), which have been reported in some CADASIL cases 43 ; gliosis (3%), as evidenced by glial fibrillary acidic protein staining, sometimes correlating with an area of microbleeding ( Figure 2F and 2G); and thrombosis (7%) and perivascular fibrin(ogen) depositions (3%) ( Figure 2H and data not shown). Notably, in 9 of 73 (12%) Notch3
Arg170Cys mice, distinct parenchymal lesions were seen, including microinfarctions characterized by foci with pallor and cell loss around small cystic cavities (5 mice) ( Figure 2I -2L). Enlargement of the Virchow-Robin spaces creating perivascular lacunae, which is also frequently detected in CADASIL, 44 All abnormalities were located within the area spanning Ϸ2.5 mm anterior to Ϸ2 mm posterior to the bregma (Supplemental Table II) .
Given the systemic nature of the arteriopathy in the Notch3
Arg170Cys mice, extracerebral organs were analyzed for pathological signs (kidney, liver, heart, lung); however, this analysis revealed no overt abnormalities (data not shown).
Arg170Cys Knock-In Mice Display Motor Defects
Clinical manifestations of CADASIL include recurrent ischemic episodes frequently causing a classic lacunar syndrome, leading to motor disability. 34, 41 We therefore monitored the same group of 73 Notch3 Arg170Cys mice up to 22 months of age for signs of motor impairment. Because variations in body weight among the mice were relative large at advanced age (eg, weight range of 35-55 g at 18 months) and influenced specific motor performance tests (eg, no differences were observed between genotypes in a grid wire hanging test or turnover test 45 after correction for body weight; data not shown), monitoring was restricted to directly observable spontaneously occurring disabilities. Nine mice (12%) developed overt permanent motor disability, ataxia, or both (Supplemental Table II ). Eight of them had paresis of 1 or more limbs, as observed by dragging of the affected limb(s) during movement. Three mice showed staggering ataxic gait. The earliest onset of motor defects observed was 13 months. Among the affected mutant mice, only 2 displayed obvious cerebral pathology on analysis after euthanization (Supplemental Table II Evaluation of changes in cognitive and complex behavioral performance, a typical symptom in CADASIL patients, 41, 46 Figure 1. Electron microscopy revealing cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy-like cerebral arteriopathy in Notch3 Arg170Cys (R170C) mutant mice. A to C, Cerebral arterioles of mutant (A and C) and wild-type (WT) (B) mice at 20 months of age showing granular osmiophilic material (GOM) deposition in the vicinity of a smooth muscle cell (SMC) in a mutant mouse (arrows in A and C). Note the tighter junction between endothelial cells (ECs), basement membrane, and SMCs in the wild-type mice (B) as compared with the mutant mice (A). C is an enlargement of the boxed zone 1 indicated in A. D and E, GOM deposition was frequently observed in enfoldings of the SMC membrane (arrows in D, E, and inset of E). This often was associated with an abundance of caveolae and endosome vesicles (arrowheads in inset of E). Note the signs of cellular necrosis in mutant mice (asterisk in D). F, GOM-like material was also seen inside caveolae in a mutant mouse (arrows in F and inset). G and H, Multilayered basement membrane in mutant mice (asterisks). Note the markedly enlarged subendothelial space filled with debris in G. H is an enlargement of the boxed zone 2 indicated in A. N indicates nucleus; SES, subendothelial space. Scale barsϭ500 nm (all panels), 250 nm (inset of E and F).
showed largely normal performance of aged Notch3 Arg170Cys mice apart from somewhat reduced exploratory behavior (Supplemental Note III and Supplemental Figure III) .
Thus, the Arg170Cys-associated pathology presented with neurological consequences affecting motor ability, reminiscent of the motor decline observed in CADASIL patients.
Arg170Cys Knock-In Mice Retain Normal Receptor Signaling
To evaluate functionality of the Arg170Cys mutant Notch3, expression of target genes (Hey1, Hey2, Nrarp, HeyL) was analyzed 23, 33 in murine embryonic fibroblasts, derived from wild-type and homozygous mutant embryos and cultured in the absence and presence of Jagged1-expressing human umbilical vein endothelial cells to induce the Notch pathway. 23 Coculture of the fibroblasts with human umbilical vein endothelial cells caused a moderate increase of Notch3 expression (1.37-fold in wild-type and somewhat higher, 2.6-fold, in the mutant fibroblasts), in line with previous reports. 23 However, coculture with human umbilical vein endothelial cells induced Notch targets to a more pronounced level (as much as Ͼ10-fold). Induction in mutant fibroblasts was somewhat reduced for Hey2 and HeyL but equal to or surpassing that in wild-type fibroblasts for the other tested targets, Hey1 and Nrarp ( Figure 3A) . Furthermore, no differences in target mRNA expression (Hey1, Hey2, Nrarp, Hes1, HeyL, Hes5) were observed in brain extracts of aged mice (20 months) ( Figure 3B) . Thus, the Arg170Cys substitution in mouse Notch3 did not affect signaling, in accordance with previous observations with the counterpart mutation in rat Notch3, which was shown to display normal surface expression, ligand binding, and signaling. 34, 47 Arg170Cys Knock-In Mice Display Normal Vascular SMC Remodeling or Growth and Normal Cerebral Capillary Densities SMC ␣-actin immunostaining did not reveal overt loss of SMCs in small cortical arteries in the Arg170Cys knock-in mice, which is in line with recent observations in mice with transgenic expression of the counterpart rat mutation 32 (SMC ␣-actin ϩ wall thickness of arterioles of 50 -150 m inner diameter: 7.3Ϯ1.8 m for Notch3
Arg170Cys mice versus 5.2Ϯ1.1 for wild-type mice; meanϮSEM, nϭ3-5, Pϭnot significant between genotypes). We also did not detect genotypic differences in expression levels of platelet-derived growth factor receptor-␤, a key molecule in vascular SMC biology, which was recently identified as a direct target gene of Notch3 20 (copies of platelet-derived growth factor receptor-␤ mRNA/10 3 copies of ␤-actin mRNA in brain extracts of 20-month-old mice were 8.9Ϯ0.90 for homozy- 
gous Notch3
Arg170Cys mice versus 8.2Ϯ0.59 for wild-type mice; meanϮSEM, nϭ3-4, Pϭnot significant). Subtle SMC defects might be present, however, as suggested by the SMC vacuolization and SMC necrosis seen by electron microscopy (see above).
Notch3 has been implicated in the development of pulmonary hypertension and associated remodeling of the small pulmonary arteries. 22 To further assess a potential impact of the Arg170Cys mutation on SMC responses, we exposed Notch3 Arg170Cys mice to chronic normobaric hypoxia (10% O 2 ) for 28 days and assessed pulmonary artery remodeling by quantification of partially and fully muscularized small peripheral lung vessels. 35 Wild-type and Notch3
Arg170Cys mice (aged 3-4 months) exposed to hypoxia developed right ventricular hypertrophy as indicated by the 1.7-fold increase in the ratio of the mass of the right ventricle to that of the left ventricle plus septum as compared with normoxia exposure ( Figure 3C ). This was associated with pulmonary arterial remodeling as revealed by the up to 3.3-fold higher fraction of completely muscularized vessels, from Ϸ10% in normoxia to Ϸ30% in hypoxia (Table) . No differences were observed, however, between wild-type and mutant mice (Table), Arg170Cys mice (aged 3-4 months) to hypoxia for 28 days. No genotypic differences were observed. MeanϮSEM, nϭ3 to 5, *PϽ0.05 vs normoxia. D to F, Vascular regeneration during skin wound healing. Healing rate of a standardized full-thickness skin wound inflicted on the back was comparable for wild-type and Notch3
Arg170Cys mice (aged 12-13 months), as monitored by daily measurement of the wound length and width (D). Both smooth muscle cell ␣-actin (SMA)-positive arterial densities (E) and total blood vessel densities (CD31 ϩ ) (F) in the wound and border area were comparable between genotypes. MeanϮSEM, nϭ5 to 6. Age of the mice was 3 to 4 mo. Data are meansϮSEM (nϭ2-5) of the number of vessels per 100 alveoli that were partially covered by SMCs (partially muscularized) or completely covered by SMCs (fully muscularized). Pϭnot significant for all comparisons between genotypes. WT indicates wild-type; SMC, smooth muscle cell.
*Average of 2. †PϽ0.05 vs corresponding genotype in normoxia.
cating that the presence of the Arg170Cys substitution per se did not impede the pulmonary arterial SMC response to hypoxia exposure. We also subjected aged mice (12-13 months) to a skin wound healing model 36 and evaluated the wound healing response and associated vessel regeneration. Healing of a full-thickness incision wound inflicted on the back of the mice progressed similarly in wild-type and mutant mice, as indicated by comparable wound closure rates ( Figure 3D) . Immunostaining of skin wound sections 14 days after wounding revealed comparable numbers of SMC ␣-actin ϩ vessels in the wound area and in the border zones in samples from Notch3
Arg170Cys mice as compared with the wild-type controls ( Figure 3E) . Total blood vessel density (CD31 staining) in the wound and border zone also did not differ between genotypes ( Figure 3F ).
Joutel et al recently reported capillary rarefaction in the cortex and corpus callosum in their mouse model with transgenic expression of mutant Arg169Cys rat Notch3, at stages before white matter lesion. 32 We therefore compared capillary densities in the brain of Notch3
Arg170Cys and wildtype control mice aged 12 to 13 months (after onset of arteriopathy) as well as in mice aged 20 to 22 months and with confirmed brain pathology, including mice with parenchymal pallor and loss. In both age groups, cortical capillary densities did not differ significantly between mutant and wild-type mice (CD31 ϩ capillary density in number per mm 2 : 242Ϯ9.5 for Notch3
Arg170Cys mice versus 264Ϯ17 for wildtype mice at 12-13 months and 283Ϯ22 for Notch3 Arg170Cys mice versus 330Ϯ17 for wild-type mice at 20 -22 months; meanϮSEM, Pϭnot significant between genotypes).
Thus, cerebral arterioles and capillaries appeared grossly normal, and neither young nor aged Notch3
Arg170Cys mice displayed overt impairment of SMC responses in selected models of vascular repair or remodeling.
Discussion
Here, we generated a mouse model of CADASIL arteriopathy and clinical disease by introducing an Arg170Cys substitution in murine Notch3, corresponding to the prevalent Arg169Cys substitution in CADASIL patients. 14, 48 This knock-in approach resulted in unperturbed expression levels in the Notch3
Arg170Cys mice and allowed direct comparative phenotyping of mutant and wild-type control littermates. Arteriopathy was observed in both the brain and peripheral sites (tail) in Notch3
Arg170Cys mice and was characterized by typical GOM deposition and enlargement of endothelial subcellular and SMC intercellular space. Histological analysis of the brain revealed microbleeds, thrombosis, fibrillar gliosis, and microinfarction, all typical features in CADASIL. 8, 9, 11, 49 As in CADASIL, 34, 41 neurological consequences affecting motor ability (ataxia, paresis) were observed. Additional similarities with CADASIL and the Notch3
Arg170Cys mouse mutant phenotype were the late onset, with hallmarks of arteriopathy observed at around 8 months (after not being present at 4 to 5 months) and the earliest signs of motor decline at 13 months, and the dominant nature of the disease.
As in CADASIL, electron microscopy of the Notch3
Arg170Cys mice revealed the presence of typical GOM-like material in the basal lamina and membrane enfoldings of the SMCs 6,27,39 but also inside caveolae. The latter, to the best of our knowledge, has not been reported before, although recently, intracellular GOM-like inclusions were observed in the Cys455Arg and Arg1031Cys human Notch3 transgenic models. 33 It is tempting to speculate that these findings may reflect stages of GOM development 33 or may relate to a postulated defective ubiquitin-dependent (trans)endocytosis of mutant Notch3. 16, 39, 50, 51 The latter is a plausible scenario, implying the presence of Notch3 ECD in GOM. This remains controversial, however, as the detection of Notch3 ECD in GOM by immunoelectron microscopy on patient material was not confirmed by mass spectrometry analysis. 33, 52 Interestingly, in vitro studies showed that CADASIL-mutant but not wild-type Notch3 ECD fragments can spontaneously form multimer aggregates, in which other proteins can coaggregate. 53 This aggregation could contribute to the observed Notch3 ECD accumulation in CADASIL and might sequester potentially critical factors by coaggregation. 33, 53 Unlike in CADASIL and in other CADASIL mouse models, 7,27,31 we did not obtain evidence for overt Notch3 ECD accumulation in the Notch3 Arg170Cys knock-in mice using a commercially available antibody. Whether and how such accumulation is critical for disease development remains to be investigated. 34 Common to several CADASIL mutations and to findings in other CADASIL models, 16, 18, 27, 30, 32 the Notch3 Arg170Cys knock-in mice developed CADASIL-like pathology in the absence of Notch signaling defects. These data are in line with the prevailing hypothesis that the effect of Notch3 mutation in CADASIL may be largely based on a neomorphic function rather than on altered signaling, 2, 7, 18, 31, 32, 34 without excluding the fact that reduced signaling reported for specific mutations can modify and further aggravate disease. 7, 31, 33 Unique so far to the Notch3 Arg170Cys knock-in model is the development of multiple features of CADASIL brain pathology, including the occurrence of microinfarctions, creating small cavities, and the development of neurological symptoms (Supplemental Table II ). Among the previously reported models, the Arg169Cys rat Notch3 transgenic model develops some of the same parenchymal pathology, primarily comprising leukoaraiosis and astrogliosis but not lacunar infarcts and possibly reflecting presymptomatic disease stage. 7, 32 Interestingly, these Arg169Cys rat Notch3 transgenic mice display white matter capillary rarefaction, which together with cerebrovascular dysfunction has been proposed to lead to the cerebral hypoperfusion observed in these mice and which possibly contributes to the white matter alterations. 7, 28, 32, 34 The normal capillary densities observed in this study in aged Notch3
Arg170Cys brains, including those from mice with confirmed brain pathology, suggests that capillary rarefaction may be an important contributing factor but possibly not a general event in mouse models of CADASILlike disease. Notch3 Arg170Cys mice experienced CADASIL-like neurological consequences affecting motor ability, including mice with microinfarction in the motor area displaying paresis of the contralateral hindlimb. In contrast, none of the other models reported so far developed neurological symptoms, despite marked overexpression of the mutant receptor in several of these transgenic lines. 7, 27, [31] [32] [33] [34] Data obtained with the Cys455Arg human Notch3 transgenic model linked this particular hypomorphic mutation to susceptibility to stroke, but the mice did not develop spontaneous infarcts. 33 The absence of brain pathology and neurological consequences in the other CADASIL mouse models was accounted for by potential differences between human and mouse cerebral vasculature, brain architecture, and vulnerability or by the short life span of mice, limiting disease development to its earlier stages. 7, 32 Although such factors might well be influencing disease outcome, the Notch3
Arg170Cys knock-in mouse model demonstrates that CADASIL-like pathology and clinical disease can develop within the life span of this species and without requiring enhanced expression of the mutant protein.
One observation on the Notch3 Arg170Cys knock-in model is the incomplete penetrance of the neurological and the brain histopathologic phenotype despite occurrence of the typical CADASIL arteriopathy in the majority of the mice. This finding suggests that arteriopathy does not cause pathological and neurological consequences per se but that modifying factors, yet to be identified, may critically influence disease development or progression. Also, the reason for the absence of cerebral pathology in some of the mice with motor disability remains unclear. We cannot, however, exclude the possibility that subtle pathological abnormalities might have escaped our analysis. Vice versa, some Notch3
Arg170Cys mice with microinfarction in the motor area did not display overt motor deficits or ataxia. However, the phenotypic outcome of similar events might differ between individual mice, in line with the highly variable clinical presentation of the disorder in CADASIL patients, even among individuals with identical mutation. 2, 16, 41 The incomplete penetrance of the Notch3 Arg170Cys phenotype may in part be accounted for by the partially outbred, mixed genetic background of the colony (129SvEv:Swiss), with differences in potential modifying genetic factors among individual mice. Genetic background differences may also contribute to the difference in phenotype and phenotype severity between the Notch3
Arg170Cys knock-in model and the other Notch3 mutant models (C57BL/6, FVB, C57BL/6:Balb/C 26, 27, [31] [32] [33] ).
In summary, this functional genetic study showed that Notch3
Arg170Cys knock-in mice developed most of the characteristic features of CADASIL neurovascular disease. Pathology and disease was late-onset, was dominant, and included not only the cerebral and peripheral arteriopathy but also several of the typical CADASIL brain pathologies, including microinfarction, as well as neurological symptoms. This novel mouse model thus may offer new opportunities to study CADASIL pathogenesis.
